TITLE

Review: Meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown

PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on a study investigating the effectiveness of meglitinide analogues (MAs) for patients with type 2 diabetes mellitus (DM). It describes the procedure and randomized controlled trials (RCTs), that were conducted during the study. The study revealed that MAs reduce the glucose level in patients with type 2 DM, but its effects on the morbidity and mortality on the patients is unknown.
ACCESSION #
28019869

 

Related Articles

  • Phone Support Does Not Improve BGs in Type1 Kids. Trecroci, D. // Diabetes Health;Feb/Mar2007, Vol. 16 Issue 1, p16 

    The article reports on the effects of phone support for children with type 1 diabetes. According to researchers, phone support does not improve blood glucose levels of diabetic children although is helpful to them. Results of a randomized controlled trial reveal that there was no improvement in...

  • Bariatric Surgery Improves Glycemic Control. Pignone, Michael // Clinical Diabetes;Summer2008, Vol. 26 Issue 3, p121 

    Design. A randomized controlled trial comparing a conventional lifestyle change intervention to conventional management plus laparoscopic adjustable gastric banding for the outcomes of "diabetes regression," defined as fasting glucose < 126 mg/dl and hemoglobin A1c (A1C) < 6.2% while using no...

  • The Importance of Strict Blood Glucose Control with Insulin Therapy in the Intensive Care Unit. Van den Heuvel, Ingeborg; Vanhorebeek, Ilse; Van den Berghe, Great // Current Diabetes Reviews;2008, Vol. 4 Issue 3, p227 

    Two randomised controlled trials have shown that maintenance of blood glucose levels below 110 mg/dl with intensive insulin therapy reduces mortality and morbidity of surgical and medical critically ill patients. An absolute reduction in the risk of death of 3-4 % is expected in...

  • The Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data. Dokken, Betsy B. // Diabetes Spectrum;Summer2008, Vol. 21 Issue 3, p150 

    The article discusses three randomized controlled trials which examined whether lowering the blood glucose to normal or near-normal would reduce the occurrence of cardiovascular events. In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, there was an increase in rates of...

  • Randomized Control Trial of Continuous Glucose Monitoring Devices on HbA1c--The MITRE Study. Newman, Stanton P.; Hurel, Steven J.; Cooke, Debbie; Steed, Elizabeth; Nunn, Andrew; Meredith, Sarah; Casbard, Angela // Diabetes;Jun2007 Supplement 1, Vol. 56, pA30 

    The article focuses on a randomized controlled trial of continuous glucose monitoring system (CGMS) on glycosylated hemoglobin. It mentions that this study aims to evaluate the efficacy of minimally invasive glucose monitoring devices in diabetics treated with insulin. It states that patients...

  • The DiGEM trial protocol -- a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. Farmer, Andrew; Wade, Alisha; French, David P.; Goyder, Elizabeth; Kinmonth, Ann Louise; Neil, Andrew // BMC Family Practice;2005, Vol. 6, p1 

    Background: The role of Prostate Specific Antigen (PSA) testing in the early detection of prostate cancer is controversial. Current UK policy stipulates that any man who wishes to have a PSA test should have access to the test, provided he has been given full information about the benefits and...

  • Continuous Glucose Monitoring-Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens. Yates, Kylie; Milton, Abul Hasnat; Dear, Keith; Ambler, Geoffrey // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1512 

    OBJECTIVE-- This randomized controlled trial assesses the effect on glycemic control of continuous glucose monitoring system (CGMS)-guided insulin therapy adjustment in young people with type 1 diabetes on intensive diabetes treatment regimens with continuous subcutaneous insulin infusion (CSII)...

  • Sensor Augmented Pump Therapy: Results of the First Treat-to-Target Study. Hirsch, Irl B.; Bode, Bruce W.; Abelseth, Jill; Fischer, Jerome S.; Kaufman, Francine R.; Mastrototaro, John; Wolpert, Howard A.; Buckingham, Bruce A. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA24 

    The article focuses on a randomized study that evaluated the clinical effectiveness of a device which combines a smart insulin pump with real-time continuous glucose monitoring (RT-CGM). Adults and adolescents with type 1 diabetes and insulin pump wearers were the participants of this study. It...

  • Evaluation of Self Monitoring of Blood Glucose in Non-Insulin-Treated Diabetic Patients by Randomized Controlled Trials: Little Bang for the Buck. Davidson, Mayer B. // Reviews on Recent Clinical Trials;Sep2010, Vol. 5 Issue 3, p138 

    Although self monitoring of blood glucose is accepted to be effective in lowering Hb A1c levels in insulin- treated diabetic patients, any benefit in non-insulin-treated patients remains controversial. Observational studies cannot answer this question because of either patient self selection...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics